Zekai Mao

Statistics

Publications

Citations

1.2K

H-Index

Active since

2015

Affiliations

Huazhong University of Science and Technology(Current)

Tongji Hospital

Union Hospital

Wuhan University of Science and Technology

Hubei Provincial Center for Disease Control and Prevention

Zekai Mao is an author at Huazhong University of Science and Technology specializing in inflammation, immunology, and inflammatory mediators in cartilage.

ORCID

Publications per year

2015–2022

Publications

Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial

Yang Cao, Jia Wei, Liang Zou et al. · Journal of Allergy and Clinical Immunology · 2020 · 475 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients

Liting Chen, Xiaolu Long, Qian Xu et al. · Cellular and Molecular Immunology · 2020 · 275 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Vanillic acid attenuates cartilage degeneration by regulating the MAPK and PI3K/AKT/NF-κB pathways

Xiaojian Huang, Xi Yang, Zekai Mao et al. · European Journal of Pharmacology · 2019 · 75 citations

Medicine, Cell Biology, Pathology +16

Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT

Jia Wei, Min Xiao, Zekai Mao et al. · Signal Transduction and Targeted Therapy · 2022 · 62 citations · Full text

Medicine, Immunology, Oncology +15

Caffeic acid protects against IL-1β-induced inflammatory responses and cartilage degradation in articular chondrocytes

Xiaojian Huang, Xi Yang, Qiyong Pan et al. · Biomedicine & Pharmacotherapy · 2018 · 60 citations

Life Sciences, Immunology, Orthopedic Surgery +17

1–5 of 14